Why the study?
What factors mediate the improvement in short-term and 1-year outcomes for patients undergoing TAVR over time?
What factors mediate the improvement in short-term and 1-year outcomes for patients undergoing TAVR over time?
Answers are grounded in this paper and cite their sources.
Improvements in short-term TAVR outcomes are primarily driven by device and procedural advances, while 1-year outcome improvements are largely due to treating younger, lower-risk patients.
While US patients undergoing transcatheter aortic valve replacement have become younger, healthier, and lower risk over time, the most important factors contributing to improvements in short-term outcomes relate to advances in device technology and procedural factors, whereas changing patient characteristics had a greater impact on improvement in 1-year outcomes.
No takes yet. Share an insight, caveat, or question.
Arnold et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: